-
1
-
-
0037661234
-
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: A randomized comparative pilot trial
-
DOI 10.1097/00002030-200306130-00008
-
Haas DW, Zala C, Schrader S, et al. Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: A randomized comparative pilot trial. AIDS 2003 ; 17: 1339-1349. (Pubitemid 36819848)
-
(2003)
AIDS
, vol.17
, Issue.9
, pp. 1339-1349
-
-
Haas, D.W.1
Zala, C.2
Schrader, S.3
Piliero, P.4
Jaeger, H.5
Nunes, D.6
Thiry, A.7
Schnittman, S.8
Sension, M.9
-
2
-
-
0033382971
-
Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection
-
Monno L, Cargnel A, Soranzo ML, et al. Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team. Antivir Ther 1999 ; 4: 195-202. (Pubitemid 30058019)
-
(1999)
Antiviral Therapy
, vol.4
, Issue.4
, pp. 195-202
-
-
Monno, L.1
Cargnel, A.2
Soranzo, M.L.3
Chirianni, A.4
Ferraro, T.5
Di Stefano, M.6
Angarano, G.7
-
3
-
-
0036954522
-
Stavudine once daily
-
DOI 10.2165/00003495-200262180-00013
-
Cheer SM, Goa KL. Stavudine once daily. Drugs 2002 ; 62: 2667-2674. (Pubitemid 36098996)
-
(2002)
Drugs
, vol.62
, Issue.18
, pp. 2667-2674
-
-
Cheer, S.M.1
Goa, K.L.2
-
4
-
-
0037322998
-
Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: Pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy [2]
-
Lopez-Cortes LF, Ruiz-Valderas R, Viciana P, et al. Once-daily saquinavir -sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: Pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy. J Acquir Immune Defic Syndr 2003 ; 32: 240-242. (Pubitemid 36222729)
-
(2003)
Journal of Acquired Immune Deficiency Syndromes
, vol.32
, Issue.2
, pp. 240-242
-
-
Lopez-Cortes, L.F.1
Ruiz-Valderas, R.2
Viciana, P.3
Mata, R.4
Gomez-Vera, J.5
Alarcon, A.6
Pachon, J.7
-
5
-
-
1642432974
-
Emtricitabine: A new nucleoside analogue for once-daily antiretroviral therapy
-
DOI 10.1517/13543784.13.1.55
-
Cahn P. Emtricitabine: A new nucleoside analogue for once-daily antiretroviral therapy. Expert Opin Investig Drugs 2004 ; 13: 55-68. (Pubitemid 38111435)
-
(2004)
Expert Opinion on Investigational Drugs
, vol.13
, Issue.1
, pp. 55-68
-
-
Cahn, P.1
-
6
-
-
0036822456
-
Simplification of antiretroviral treatment - How to sustain success, reduce toxicity and ensure adherence avoiding PI use
-
Barreiro P, Garcia-Benayas T, Soriano V, Gallant J. Simplification of antiretroviral treatment - how to sustain success, reduce toxicity, and ensure adherence avoiding PI use. AIDS Rev 2002 ; 4: 233-241. (Pubitemid 36104234)
-
(2002)
AIDS Reviews
, vol.4
, Issue.4
, pp. 233-241
-
-
Barreiro, P.1
Garcia-Benayas, T.2
Soriano, V.3
Gallant, J.4
-
7
-
-
9144250171
-
Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542
-
DOI 10.1128/AAC.48.2.423-429.2004
-
Jacobson JM, Israel RJ, Lowry I, et al. Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542. Antimicrob Agents Chemother 2004 ; 48: 423-429. (Pubitemid 38141697)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.2
, pp. 423-429
-
-
Jacobson, J.M.1
Israel, R.J.2
Lowy, I.3
Ostrow, N.A.4
Vassilatos, L.S.5
Barish, M.6
Tran, D.N.H.7
Sullivan, B.M.8
Ketas, T.J.9
O'Neill, T.J.10
Nagashima, K.A.11
Huang, W.12
Petropoulos, C.J.13
Moore, J.P.14
Maddon, P.J.15
Olson, W.C.16
-
8
-
-
0141462781
-
Simplified regimens for treating HIV infection and AIDS
-
Piliero PJ, Colagreco JP. Simplified regimens for treating HIV infection and AIDS. J Am Acad Nurse Pract 2003 ; 15: 305-312.
-
(2003)
J Am Acad Nurse Pract
, vol.15
, pp. 305-312
-
-
Piliero, P.J.1
Colagreco, J.P.2
-
9
-
-
0347992034
-
Equivalent Steady-State Pharmacokinetics of Lamivudine in Plasma and Lamivudine Triphosphate within Cells following Administration of Lamivudine at 300 Milligrams Once Daily and 150 Milligrams Twice Daily
-
DOI 10.1128/AAC.48.1.176-182.2004
-
Yuen GJ, Lou Y, Bumgarner NF, et al. Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily. Antimicrob Agents Chemother 2004 ; 48: 176-182. (Pubitemid 38040195)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.1
, pp. 176-182
-
-
Yuen, G.J.1
Lou, Y.2
Bumgarner, N.F.3
Bishop, J.P.4
Smith, G.A.5
Otto, V.R.6
Hoelscher, D.D.7
-
10
-
-
0032062733
-
Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients
-
Gallant JE, Block DS. Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients. J Int Assoc Physicians AIDS Care 1998 ; 4: 32-35.
-
(1998)
J Int Assoc Physicians AIDS Care
, vol.4
, pp. 32-35
-
-
Gallant, J.E.1
Block, D.S.2
-
11
-
-
0344514153
-
Once-Daily Administration of Antiretrovirals: Pharmacokinetics of Emerging Therapies
-
DOI 10.2165/00003088-200342140-00001
-
Taburet AM, Paci-Bonaventure S, Peytavin G, Molina JM. Once-daily administration of antiretrovirals: Pharmacokinetics of emerging therapies. Clin Pharmacokinet 2003 ; 42: 1179-1191. (Pubitemid 37491485)
-
(2003)
Clinical Pharmacokinetics
, vol.42
, Issue.14
, pp. 1179-1191
-
-
Taburet, A.-M.1
Paci-Bonaventure, S.2
Peytavin, G.3
Molina, J.-M.4
-
12
-
-
0035477744
-
Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study
-
DOI 10.1097/00126334-200110010-00003
-
Stone VE, Hogan JW, Schuman P, et al. HERS Study. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: A survey of women in the HER study. J Acquir Immune Defic Syndr 2001: 28: 124-131. (Pubitemid 32971059)
-
(2001)
Journal of Acquired Immune Deficiency Syndromes
, vol.28
, Issue.2
, pp. 124-131
-
-
Stone, V.E.1
Hogan, J.W.2
Schuman, P.3
Rompalo, A.M.4
Howard, A.A.5
Korkontzelou, C.6
Smith, D.K.7
-
13
-
-
0037391631
-
Adherence to HAART regimens
-
DOI 10.1089/108729103321619773
-
Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS 2003 ; 17: 169-177. (Pubitemid 36444006)
-
(2003)
AIDS Patient Care and STDs
, vol.17
, Issue.4
, pp. 169-177
-
-
Chesney, M.1
-
14
-
-
0036731778
-
Patient preferences regarding antiretroviral therapy
-
DOI 10.1258/09564620260216281
-
Miller LG, Huffman HB, Weidmer BA, Hays RD. Patient preferences regarding antiretroviral therapy. Int J STD AIDS 2002 ; 13: 593-601. (Pubitemid 34983492)
-
(2002)
International Journal of STD and AIDS
, vol.13
, Issue.9
, pp. 593-601
-
-
Miller, L.G.1
Huffman, H.B.2
Weidmer, B.A.3
Hays, R.D.4
-
15
-
-
1542646440
-
Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care
-
Cohen C, Elion RA, Frank I, et al. Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care. J Int Assoc Physicians AIDS Care 2002 ; 1: 141-145.
-
(2002)
J Int Assoc Physicians AIDS Care
, vol.1
, pp. 141-145
-
-
Cohen, C.1
Elion, R.A.2
Frank, I.3
-
16
-
-
0344760902
-
-
Panel on Clinical Practices for Treatment of HIV Infection Department of Health Human Services (DHHS). Available from:
-
Fauci AS, Bartlett JG (Co-chairs). Panel on Clinical Practices for Treatment of HIV Infection. Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. March 23, 2004. [cited 2004 May 3]. P. 20. Available from: http://AIDSinfo.nih.gov
-
(2004)
Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents
, pp. 20
-
-
Fauci, A.S.1
Bartlett, J.G.2
-
17
-
-
9144233476
-
Once-Daily versus Twice-Daily Lopinavir/Ritonavir in Antiretroviral-Naive HIV-Positive Patients: A 48-Week Randomized Clinical Trial
-
DOI 10.1086/380799
-
Eron JJ, Feinberg J, Kessler HA, et al. Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: A 48-week randomized clinical trial. J Infect Dis 2004 ; 189: 265-272. (Pubitemid 38147251)
-
(2004)
Journal of Infectious Diseases
, vol.189
, Issue.2
, pp. 265-272
-
-
Eron, J.J.1
Feinberg, J.2
Kessler, H.A.3
Horowitz, H.W.4
Witt, M.D.5
Carpio, F.F.6
Wheeler, D.A.7
Ruane, P.8
Mildvan, D.9
Yangco, B.G.10
Bertz, R.11
Bernstein, B.12
King, M.S.13
Sun, E.14
-
19
-
-
0033847883
-
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients
-
DOI 10.1086/315711
-
Molina JM, Ferchal F, Rancinan C, et al. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. J Infect Dis 2000 ; 182: 599-602. (Pubitemid 30651060)
-
(2000)
Journal of Infectious Diseases
, vol.182
, Issue.2
, pp. 599-602
-
-
Molina, J.-M.1
Ferchal, F.2
Rancinan, C.3
Raffi, F.4
Rozenbaum, W.5
Sereni, D.6
Morlat, P.7
Journot, V.8
Decazes, J.-M.9
Chene, G.10
-
20
-
-
0035393638
-
A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection
-
Mole L, Schmidgall D, Holodniy M. A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection. J Acquir Immune Defic Syndr 2001 ; 27: 260-265. (Pubitemid 32661967)
-
(2001)
Journal of Acquired Immune Deficiency Syndromes
, vol.27
, Issue.3
, pp. 260-265
-
-
Mole, L.1
Schmidgall, D.2
Holodniy, M.3
-
21
-
-
0035715574
-
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
-
Maggiolo F, Migliorino M, Maserati R, et al. Once Study Group. Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine, and efavirenz. Antivir Ther 2001 ; 6: 249-253. (Pubitemid 34174763)
-
(2001)
Antiviral Therapy
, vol.6
, Issue.4
, pp. 249-253
-
-
Maggiolo, F.1
Migliorino, M.2
Maserati, R.3
Pan, A.4
Rizzi, M.5
Pravettoni, G.6
Rizzi, L.7
Suter, F.8
-
22
-
-
0346992391
-
Nevirapine plus efavirenz plus didanosine: A simple, safe, and effective once-daily regimen for patients with HIV infection
-
Jordan WC, Jefferson R, Yemofio F, et al. Nevirapine plus efavirenz plus didanosine: A simple, safe, and effective once-daily regimen for patients with HIV infection. J Natl Med Assoc 2003 ; 95: 1152-1157. (Pubitemid 38017892)
-
(2003)
Journal of the National Medical Association
, vol.95
, Issue.12
, pp. 1152-1157
-
-
Jordan, W.C.1
Jefferson, R.2
Yemofio, F.3
Tolbert, L.4
Conlon, V.5
Carroll, H.6
Christopher Creen, D.7
Green, A.8
Green, R.9
-
23
-
-
0042324086
-
Once-a-day therapy for HIV infection: A controlled, randomized study in antiretroviral-naive HIV-1-infected patients
-
Maggiolo F, Ripamonti D, Gregis G, et al. Once-a-day therapy for HIV infection: A controlled, randomized study in antiretroviral-naive HIV-1-infected patients. Antivir Ther 2003 ; 8: 339-346. (Pubitemid 37101638)
-
(2003)
Antiviral Therapy
, vol.8
, Issue.4
, pp. 339-346
-
-
Moggiolo, F.1
Ripamonti, D.2
Gregis, G.3
Quinzan, G.4
Callegaro, A.5
Arici, C.6
Ravasio, L.7
Suter, F.8
-
24
-
-
0032971472
-
Ritonavir and saquinavir combination therapy for the treatment of HIV infection
-
DOI 10.1097/00002030-199902040-00009
-
Cameron DW, Japour AJ, Xu Y, et al. Ritonavir and saquinavir in combination therapy for the treatment of HIV infection. AIDS 1999 ; 13: 213-224. (Pubitemid 29050409)
-
(1999)
AIDS
, vol.13
, Issue.2
, pp. 213-224
-
-
Cameron, D.W.1
Japour, A.J.2
Xu, Y.3
Hsu, A.4
Mellors, J.5
Farthing, C.6
Cohen, C.7
Poretz, D.8
Markowitz, M.9
Follansbee, S.10
Angel, J.B.11
McMahon, D.12
Ho, D.13
Devanarayan, V.14
Rode, R.15
Salgo, M.P.16
Kempf, D.J.17
Granneman, R.18
Leonard, J.M.19
Sun, E.20
more..
-
25
-
-
0037024757
-
6/l
-
DOI 10.1097/00002030-200207050-00009
-
Opravil M, Ledergerber B, Furrer H, et al. Swiss HIV Cohort Study. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 count >350 x 106/I. AIDS 2002 ; 16: 1371-1381. (Pubitemid 34722069)
-
(2002)
AIDS
, vol.16
, Issue.10
, pp. 1371-1381
-
-
Opravil, M.1
Ledergerber, B.2
Furrer, H.3
Hirschel, B.4
Imhof, A.5
Gallant, S.6
Wagels, T.7
Bernasconi, E.8
Meienberg, F.9
Rickenbach, M.10
Weber, R.11
-
26
-
-
0036534655
-
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection
-
Giorgi JV, Lyles RH, Matud JL, et al. Multicenter AIDS Cohort Study. Predictive value of immunologic and virologic markers after long or short duration of HIV- 1 infection. J Acquir Immune Defic Syndr 2002 ; 29: 346-355. (Pubitemid 34288887)
-
(2002)
Journal of Acquired Immune Deficiency Syndromes
, vol.29
, Issue.4
, pp. 346-355
-
-
Giorgi, J.V.1
Lyles, R.H.2
Matud, J.L.3
Yamashita, T.E.4
Mellors, J.W.5
Hultin, L.E.6
Jamieson, B.D.7
Margolick, J.B.8
Rinaldo Jr., C.R.9
Phair, J.P.10
Detels, R.11
-
27
-
-
0033943843
-
Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS
-
DOI 10.1086/315687
-
Vanhems P, Hirschel B, Phillips AN, et al. Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis 2000 ; 182: 334-337. (Pubitemid 30497826)
-
(2000)
Journal of Infectious Diseases
, vol.182
, Issue.1
, pp. 334-337
-
-
Vanhems, P.1
Hirschel, B.2
Phillips, A.N.3
Cooper, D.A.4
Vizzard, J.5
Brassard, J.6
Perrin, L.7
-
28
-
-
0037111623
-
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City
-
DOI 10.1086/343048
-
Shah SS, McGowan JP, Smith C, Blun S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis 2002 ; 35: 1238-1243. (Pubitemid 35305872)
-
(2002)
Clinical Infectious Diseases
, vol.35
, Issue.10
, pp. 1238-1243
-
-
Shah, S.S.1
McGowan, J.P.2
Smith, C.3
Blum, S.4
Klein, R.S.5
-
29
-
-
0037114852
-
AdICoNA Study Group. Treatment-related factors and highly active antiretroviral therapy adherence
-
Trotta MP, Ammassari A, Melzi S, et al. AdICoNA Study Group. Treatment-related factors and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002 ; 31 Suppl 3: S128 - S131.
-
(2002)
J Acquir Immune Defic Syndr
, vol.31
, Issue.SUPPL. 3
-
-
Trotta, M.P.1
Ammassari, A.2
Melzi, S.3
-
30
-
-
0036842327
-
Looking beyond highly active antiretroviral therapy: Drug-related hepatotoxicity in patients with human immunodeficiency virus infection
-
Orenstein R, Tsogas N. Looking beyond highly active antiretroviral therapy: Drug-related hepatotoxicity in patients with human immunodeficiency virus infection. Pharmacotherapy 2002 ; 22: 1468-1478. (Pubitemid 35266383)
-
(2002)
Pharmacotherapy
, vol.22
, Issue.11
, pp. 1468-1478
-
-
Orenstein, R.1
Tsogas, N.2
-
31
-
-
0036260173
-
Psychological symptoms among persons 50 years of age and older living with HIV disease
-
Heckman TG, Heckman BD, Kochman A, Sikkema KJ, Suhr J, Goodkin K. Psychological symptoms among persons 50 years of age and older living with HIV disease. Aging Ment Health 2002 ; 6: 121-128. (Pubitemid 34587158)
-
(2002)
Aging and Mental Health
, vol.6
, Issue.2
, pp. 121-128
-
-
Heckman, T.G.1
Heckman, B.D.2
Kochman, A.3
Sikkema, K.J.4
Suhr, J.5
Goodkin, K.6
-
32
-
-
0035668496
-
Justification for a new cohort study of people aging with and without HIV infection
-
Justice AC, Landefeld CD, Asch SM, Gifford AL, Whalen CC, Covinsky KE. Justification for a new cohort study of people aging with and without HIV infection. J Clin Epidemiol 2001 ; 54 Suppl 1: S3 - S8.
-
(2001)
J Clin Epidemiol
, vol.54
, Issue.SUPPL. 1
-
-
Justice, A.C.1
Landefeld, C.D.2
Asch, S.M.3
Gifford, A.L.4
Whalen, C.C.5
Covinsky, K.E.6
-
33
-
-
0033754842
-
Using routine data to complement and enhance the results of randomised controlled trials
-
Lewsey JD, Leyland AH, Murray GD, Boddy FA. Using routine data to complement and enhance the results of randomised controlled trials. Health Technol Assess 2000 ; 4: 1-55.
-
(2000)
Health Technol Assess
, vol.4
, pp. 1-55
-
-
Lewsey, J.D.1
Leyland, A.H.2
Murray, G.D.3
Boddy, F.A.4
-
34
-
-
0034457843
-
Factors affecting adherence to antiretroviral therapy
-
Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000 ; 30 Suppl 2: S171 - S176.
-
(2000)
Clin Infect Dis
, vol.30
, Issue.SUPPL. 2
-
-
Chesney, M.A.1
-
35
-
-
0037065355
-
Interventions to enhance patient adherence to medication prescriptions: Scientific review
-
DOI 10.1001/jama.288.22.2868
-
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: Scientific review. JAMA 2002 ; 288: 2868-2879. (Pubitemid 35425073)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.22
, pp. 2868-2879
-
-
McDonald, H.P.1
Garg, A.X.2
Haynes, R.B.3
|